Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 275 Carcinoma, Intraductal, Noninfiltrating 25 Breast Carcinoma In Situ 21 Neoplasm Metastasis 14 Neoplasms 13 Breast Neoplasms, Male 12 Ovarian Neoplasms 10 Inflammatory Breast Neoplasms 7 Glioblastoma 6 Endometrial Neoplasms 6 Prostatic Neoplasms 5 Central Nervous System Neoplasms 5 Gliosarcoma 4 Fallopian Tube Neoplasms 4 Breast Cancer Female 4 Brain Neoplasms 4 Recurrence 3 Obesity 3 Hot Flashes 3 Glioma 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Ductal, Breast 3 Breast Diseases 3 Astrocytoma 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Sleep Wake Disorders 2 Sarcoma 2 Pancreatic Neoplasms 2 Oligodendroglioma 2

Interventions

Metformin 152 Clomiphene 52 Letrozole 41 Inositol 34 Folic Acid 18 Progesterone 17 Exercise 17 Ethinyl Estradiol 13 Estradiol 13 Chorionic Gonadotropin 13 Caloric Restriction 13 drospirenone and ethinyl estradiol combination 12 Contraceptives, Oral 12 cetrorelix 11 Pioglitazone 10 High-Intensity Interval Training 10 Cholecalciferol 10 Triptorelin Pamoate 9 Tablets 9 Spironolactone 9 Menotropins 8 Diet 8 Vitamin D 7 Thioctic Acid 7 Surveys and Questionnaires 7 Liraglutide 7 Gonadotropins 7 Acupuncture Therapy 7 follitropin alfa 6 drospirenone 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Polycystic Ovary Syndrome × Tamoxifen × Clear all

NCT07616973 2026-06-01

LET-CC-TAM

Sana'a University

Phase 3 Active not recruiting

Anovulation, Infertility, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡